Synthetic cellular IL-1B is rapidly becoming the essential resource for investigators across multiple fields. The precisely produced form of interleukin-1 beta offers advantages over naturally occurring IL-1B, such as enhanced quality and predictable activity. Scientists are leveraging it to better understand a part of IL-1B in complex immune proce